Paper31399545
ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer.
Hashimoto S and 18 others. Proc Natl Acad Sci U S A, 2019. Cited by 122 papers, by iCite.
Cite this record
ConductScience Library. ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer. Papers, record 31399545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31399545
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ADP-Ribosylation Factors | Major topic |
| B7-H1 Antigen | Major topic |
| Immune Evasion | Major topic |
| Pancreatic Neoplasms | Major topic |
| Proto-Oncogene Proteins p21(ras) | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| ADP-Ribosylation Factor 6 | |
| Binding Sites | |
| Biomarkers, Tumor | |
| Cell Line, Tumor | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Immunohistochemistry | |
| Models, Molecular | |
| Mutation | |
| Prognosis | |
| Protein Binding | |
| RNA, Messenger | |
| Receptors, Platelet-Derived Growth Factor | |
| Signal Transduction |
Source PubMed
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12091876 | Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. | Nat Med | 2002 | https://conductscience.org/library/papers/12091876 | PubMed |
| 2 | 12482958 | The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/12482958 | PubMed |
| 3 | 12509763 | Targeting RAS signalling pathways in cancer therapy. | Nat Rev Cancer | 2003 | https://conductscience.org/library/papers/12509763 | PubMed |
| 4 | 12957286 | Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. | Cancer Cell | 2003 | https://conductscience.org/library/papers/12957286 | PubMed |
| 5 | 14607973 | Requirement for Arf6 in cell adhesion, migration, and cancer cell invasion. | J Biochem | 2003 | https://conductscience.org/library/papers/14607973 | PubMed |
| 6 | 14681207 | Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. | Genes Dev | 2003 | https://conductscience.org/library/papers/14681207 | PubMed |
| 7 | 14706336 | Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. | Cancer Cell | 2003 | https://conductscience.org/library/papers/14706336 | PubMed |
| 8 | 15059920 | The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. | Cancer Res | 2004 | https://conductscience.org/library/papers/15059920 | PubMed |
| 9 | 15087504 | Requirement for Arf6 in breast cancer invasive activities. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15087504 | PubMed |
| 10 | 15719014 | Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. | EMBO J | 2005 | https://conductscience.org/library/papers/15719014 | PubMed |
| 11 | 15894267 | Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. | Cancer Cell | 2005 | https://conductscience.org/library/papers/15894267 | PubMed |
| 12 | 16839880 | TIGAR, a p53-inducible regulator of glycolysis and apoptosis. | Cell | 2006 | https://conductscience.org/library/papers/16839880 | PubMed |
| 13 | 17404099 | Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17404099 | PubMed |
| 14 | 18084281 | GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. | Nat Cell Biol | 2008 | https://conductscience.org/library/papers/18084281 | PubMed |
| 15 | 18551192 | Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18551192 | PubMed |
| 16 | 18772397 | Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. | Science | 2008 | https://conductscience.org/library/papers/18772397 | PubMed |
| 17 | 18794329 | EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial-mesenchymal transition. | J Cell Biol | 2008 | https://conductscience.org/library/papers/18794329 | PubMed |
| 18 | 19077451 | Genome-wide analysis of pancreatic cancer using microarray-based techniques. | Pancreatology | 2009 | https://conductscience.org/library/papers/19077451 | PubMed |
| 19 | 19416474 | The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis. | Traffic | 2009 | https://conductscience.org/library/papers/19416474 | PubMed |
| 20 | 19935649 | The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. | Nat Cell Biol | 2009 | https://conductscience.org/library/papers/19935649 | PubMed |
Cited by95
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42828639 | Programmed cell death protein 4 (PDCD4): a pleiotropic regulator in cardiovascular diseases. | J Physiol Biochem | 2026 | https://conductscience.org/library/papers/42828639 | PubMed |
| 42792545 | Mechanisms of Immune Cell Dysregulation in Pancreatic Ductal Adenocarcinoma. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42792545 | PubMed |
| 42712971 | RAS signaling and remodeling of the immune microenvironment in pancreatic ductal adenocarcinoma: implications of emerging RAS-targeted therapy. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42712971 | PubMed |
| 42524620 | Intracellular PD-L1: Functions, Regulation, and Therapeutic Implications. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42524620 | PubMed |
| 42157944 | Surfactant Protein B Precursor Inhibit the Progression of Resectable Non-small Cell Lung Cancer by Suppressing eIF4F-mediated Immune Evasion and Cancer Stemness. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42157944 | PubMed |
| 42149255 | Peptides as integrative modulators for clinical prognosis and targeted therapy in pancreatic cancer. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42149255 | PubMed |
| 41069763 | Responsive nanomedicine strategies achieve pancreatic cancer precise theranostics. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41069763 | PubMed |
| 41068090 | CRISPR-Cas9 screening reveals G2E3 as a novel ubiquitin-linked factor controlling autophagosome-lysosome fusion and cancer cell progression. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/41068090 | PubMed |
| 40918466 | Polyphenols in Pancreatic Cancer Management: Exploring the Roles and Mechanisms of Resveratrol and Epigallocatechin. | Oncol Res | 2025 | https://conductscience.org/library/papers/40918466 | PubMed |
| 40898094 | KRAS mutation promotes immune escape of lung adenocarcinoma via ZNF24/SLC7A5/PD-L1 axis. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40898094 | PubMed |
| 40611261 | Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle? | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40611261 | PubMed |
| 40542378 | Identification and validation of ARF6 for a potential prognostic biomarker of acute myeloid leukemia. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40542378 | PubMed |
| 40410613 | Methuosis key gene ARF6 as a diagnostic, prognostic and immunotherapeutic marker for prostate cancer: based on a comprehensive pan-cancer multi-omics analysis. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40410613 | PubMed |
| 40275490 | ARF6 Promotes AML Progression via Activation of PI3K/AKT/mTOR Signaling. | Cancer Med | 2025 | https://conductscience.org/library/papers/40275490 | PubMed |
| 40270615 | Acute aerobic exercise alters serum protein distribution in colorectal cancer patients. | Front Oncol | 2025 | https://conductscience.org/library/papers/40270615 | PubMed |
| 40075634 | KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40075634 | PubMed |
| 39883638 | Effect of cytotoxic CD8+ T-cells secretory proteins on hypoxic pancreatic cancer cells. | PLoS One | 2025 | https://conductscience.org/library/papers/39883638 | PubMed |
| 39866192 | ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 Inversely Regulates Programmed Death-Ligand 1 Through Negative Feedback of Phosphorylated Epithelial Growth Factor Receptor and Activation of Nuclear Factor-Kappa B in Non-Small Cell Lung Cancer. | Cancer Manag Res | 2025 | https://conductscience.org/library/papers/39866192 | PubMed |
| 39857640 | DRG2 as a Biomarker to Enhance the Predictive Efficacy of PD-L1 Immunohistochemistry Assays. | Biomedicines | 2024 | https://conductscience.org/library/papers/39857640 | PubMed |
| 39796673 | Components of the Endosome-Lysosome Vesicular Machinery as Drivers of the Metastatic Cascade in Prostate Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39796673 | PubMed |
Genes39
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31399545
GET https://conductscience.org/api/papers/v1/31399545/references?page=2